Wellfully Limited, together with its subsidiaries, develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Singapore and Europe. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. It develops magnetic micro-array and powerless drug delivery technologies; and designs and develops drug patches, applicators, and brushes products. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.
| Market Capitalization | $14.7384 million |
| P/E Ratio | |
| P/E Growth Ratio | |
| Book Value | 0.012 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.037 |
| EBITDA | |
| Profit Margin | 0 |
| Operating Margin TTM | -5.3149 |
| Return on Assets TTM | -1.4786 |
| Return on Equity TTM | -3.6307 |
| Revenue TTM | 1,408.771 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2015-12-31 | 1,521.57 | |||
| 2016-12-31 | 1,966.22 | 46.285 | -46.285 | |
| 2017-12-31 | 2,039.99 | 48.186 | -48.186 | |
| 2018-12-31 | 2,744.78 | 65.675 | 1,183.685 | |
| 2019-12-31 | 1,484.22 | 271.699 | -204.943 | |
| 2020-12-31 | 1,203.34 | 883.701 | -420.728 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2015-12-31 | 7,843.1 | 567.33 | 210 | 31,346.22 | ||
| 2016-12-31 | 5,373.442 | 6,206.09 | 504.04 | 224 | 31,766.487 | |
| 2017-12-31 | 4,176.062 | 4,806.34 | 550.93 | 238 | 33,043.514 | |
| 2018-12-31 | 2,251.91 | 3,136.569 | 591.161 | 33,043.514 | ||
| 2019-12-31 | 612.172 | 1,191.55 | 2,410.58 | 1,007.05 | 33,043.514 | |
| 2020-12-31 | 2,725.636 | 3,392.06 | 1,083.45 | 154 | 42,552.152 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2015-12-31 | -2,242.04 | 3,814.87 | 7,334.205 | |||
| 2016-12-31 | -3,044.208 | -1,686.354 | -1,960.763 | 7,334.205 | 5,373.442 | |
| 2017-12-31 | -1,698.783 | -1,427.742 | -1,197.38 | 5,373.442 | 4,176.062 | |
| 2018-12-31 | -1,710.001 | -1,876.4 | -1,924.152 | 4,176.062 | 2,251.91 | |
| 2019-12-31 | -3,713.117 | -2,676.566 | -1,639.738 | 2,251.91 | 612.172 | |
| 2020-12-31 | -6,397.257 | -5,201.882 | 2,113.464 | 612.172 | 2,725.636 |